Fortis Supreme Court: Challenges Alter Ego Forensic Audit Mandate

• Fortis Healthcare Limited has appealed to the Supreme Court against a Delhi High Court order from August 31, 2026, mandating a forensic audit of its shares and transactions.
• The audit is part of enforcement proceedings for Daiichi Sankyo's ₹5,300 crore arbitral award against former Fortis promoters Malvinder and Shivinder Singh.
• Fortis argues that as a listed company, it is not an alter ego of its promoters and should not face an open-ended forensic inquiry without a legal basis for piercing its corporate veil.
• The Delhi High Court's order appointed S Ramanand Aiyar & Co. to audit Fortis share transactions from May 24, 2016, including FHHPL's shareholding, bank transactions, and major investments.
• The case is expected to clarify the application of the 'alter ego' doctrine and corporate veil piercing in India, particularly for listed companies and the enforcement of arbitral awards.

Fortis asserts that the High Court's directive effectively treats the company as an "alter ego" of the Singh brothers, despite the absence of a clear legal or factual foundation for piercing the corporate veil.

Fortis Healthcare Limited has initiated a challenge before the Supreme Court, contesting a directive issued by the Delhi High Court on August 31, 2026. This High Court order mandated a comprehensive forensic audit into the movement of Fortis shares and associated transactions. The audit forms a critical part of the ongoing enforcement proceedings related to an arbitral award secured by Daiichi Sankyo against the former promoters of Fortis, Malvinder Mohan Singh and Shivinder Mohan Singh.

In its Special Leave Petition, Fortis argues that as a publicly listed entity, it was neither a party to the original arbitration nor is it a judgment debtor in the case. Consequently, the company contends it should not be subjected to an open-ended forensic inquiry based solely on the alleged conduct of its erstwhile promoters. Fortis asserts that the High Court's directive effectively treats the company as an "alter ego" of the Singh brothers, despite the absence of a clear legal or factual foundation for piercing the corporate veil.

The contested order, issued by Justice Subramonium Prasad, approved three applications seeking an investigation into the alleged dissipation of assets. To conduct this extensive probe, S Ramanand Aiyar & Co., Chartered Accountants, was appointed as the forensic auditor. The audit's primary objective is to meticulously reconstruct the entire chain of transactions involving Fortis shares, commencing from May 24, 2016, a date significant as it marks the first assurance given regarding the preservation of assets.

The auditor's mandate includes a detailed examination of the evolution of Fortis Healthcare Holdings Pvt Ltd (FHHPL)'s shareholding, encompassing the creation and invocation of pledges, subsequent top-ups, the release of securities, and the sale of pledged shares, alongside any other transactions impacting the shareholding. Furthermore, the audit is tasked with scrutinizing transactions involving various banks and financial institutions. This includes determining whether loans obtained by downstream entities represented genuine business activities or if they contributed to the dissipation of assets that could otherwise have been available for the execution of the arbitral award.

Additional areas of scrutiny for the forensic audit involve the significant 2018 investment by IHH Healthcare Berhad/Northern TK Venture, which infused approximately ₹4,000 crore through a fresh issue of Fortis shares. The audit will also delve into Fortis's subsequent transaction with RHT Health Trust, Singapore, valued at approximately ₹4,666 crore. For these major transactions, the High Court directed an examination of their structure, regulatory approvals, filings, the movement of shares, and the ultimate utilization of the funds. The High Court's decision drew substantial support from earlier Supreme Court proceedings, particularly the 2022 ruling in Daiichi Sankyo Co. Ltd. v. Oscar Investments Ltd., where the apex court had instructed executing courts to consider forensic audits for transactions involving banks.

The origins of this complex legal battle trace back to an arbitral award issued in Singapore on April 29, 2016. This award directed the Singh brothers and other judgment debtors to remit approximately ₹2,562 crore to Daiichi Sankyo, inclusive of pre-award and post-award interest. The validity of this award was subsequently affirmed through proceedings in India. Daiichi Sankyo has since stated that the total outstanding amount has escalated to approximately ₹5,300 crore.

The enforcement proceedings took on a new dimension following concerns raised regarding the significant diminution of the Singh brothers’ shareholding in Fortis. At the time the arbitral award was initially granted, entities under the control of the brothers, such as Fortis Healthcare Holdings Pvt Ltd (FHHPL), held a substantial stake in Fortis. In 2016-17, the Delhi High Court had recorded assurances that the value of certain unencumbered Fortis shares would be preserved specifically for the satisfaction of the award. Subsequently, the Supreme Court issued a directive mandating the maintenance of status quo concerning FHHPL’s shareholding in Fortis.

The core of Fortis's challenge revolves around the application of the 'alter ego' doctrine and the circumstances under which the corporate veil of a listed company can be lifted. Fortis contends that the Delhi High Court's order effectively treated it as an alter ego of its former promoters without establishing the necessary legal or factual basis for such a determination. This argument is central to the `Fortis Supreme Court alter ego forensic audit` case.

This legal dispute is poised to provide crucial clarity on the `corporate veil lifting India listed company` framework, particularly concerning the enforcement of arbitral awards against promoters and the potential targeting of a public company's assets for their liabilities. The outcome of this `Special Leave Petition forensic probe` will have significant implications for corporate governance, promoter liability, and the scope of forensic audits in India, especially for publicly traded entities.

This case will provide critical clarity on the application of the 'alter ego' doctrine and corporate veil piercing in India, particularly concerning listed companies and the enforcement of arbitral awards against their promoters. Lawyers and compliance officers should monitor the Supreme Court's decision to understand the potential scope of forensic audits and the circumstances under which a public company's assets may be targeted for liabilities of its erstwhile promoters, impacting corporate governance and enforcement strategies.

Source: Original reporting via Live Law